Uroplasty, Inc. (AMEX: UPI), a global medical device company, is focused on developing, manufacturing, and marketing products for the minimally invasive treatment of voiding dysfunctions and pelvic disorders. The company offers a wide range of products that meet the demands of healthcare professionals and patients. Their devices help healthcare professionals increase the efficiency of their treatment options while reducing patient risk. For further information, visit the Company’s web site at www.uroplasty.com.
- 17 years ago
QualityStocks
Uroplasty, Inc. (AMEX: UPI)
Tags Rodman & Renshaw
Related Post
-
New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Looks Forward to Bolivia Presidential Runoff, Hoping for Increased Foreign Investment Support
Bolivia heads into an October presidential runoff, signaling a possible shift toward more pro-business policies,…
-
Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF): Building Value Through Nevada’s Walker Lane
Four-property portfolio in Nevada’s Walker Lane anchored by the Santa Fe Mine project with over…
-
ONAR Holding Corp. (ONAR) Powers Smarter Marketing with Agency Innovation
As budgets tighten and demands intensify, CMOs are questioning traditional marketing models ONAR is seizing…